首页|期刊导航|癌症生物学与医学（英文版）|First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients
First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patientsOA
First-line immunotherapy for advanced HER2-negative gastric cancer:differences between Asian and non-Asian patients
Chuanhua Zhao;Sisi Ye;Meng Chen;Jing Qian;Jianming Xu
The Fifth Medical Center,Chinese PLA General Hospital,Beijing 100071,ChinaThe Fifth Medical Center,Chinese PLA General Hospital,Beijing 100071,ChinaValue&Implementation,MSD China,Shanghai 200030,ChinaValue&Implementation,MSD China,Shanghai 200030,ChinaThe Fifth Medical Center,Chinese PLA General Hospital,Beijing 100071,China
Asiagastric cancerHER2-negativeimmunotherapy
Asiagastric cancerHER2-negativeimmunotherapy
《癌症生物学与医学（英文版）》 2026 (2)
201-217,17
This manuscript was funded by MSD China.This work was supported by grants from Non-communicable Chronic Diseases-National Science and Technology Major Project(Grant No.2024ZD0520600).
评论